Related Experiment Video
Updated: May 10, 2026

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc
Y Sun1, P Y Liu1, C J Scarlett2
1Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia.
Abstract:
The N-Myc oncoprotein induces neuroblastoma, which arises from undifferentiated neuroblasts in the sympathetic nervous system, by modulating gene and protein expression and consequently causing cell differentiation block and cell proliferation. The class IIa histone deacetylase 5 (HDAC5) represses gene transcription, and blocks myoblast, osteoblast and leukemia cell differentiation. Here we showed that N-Myc upregulated HDAC5 expression in neuroblastoma cells. Conversely, HDAC5 repressed the ubiquitin-protein ligase NEDD4 gene expression, increased Aurora A gene expression and consequently upregulated N-Myc protein expression. Genome-wide gene expression analysis and protein co-immunoprecipitation assays revealed that HDAC5 and N-Myc repressed the expression of a common subset of genes by forming a protein complex, whereas HDAC5 and the class III HDAC SIRT2 independently repressed the expression of another common subset of genes without forming a protein complex. Moreover, HDAC5 blocked differentiation and induced proliferation in neuroblastoma cells. Taken together, our data identify HDAC5 as a novel co-factor in N-Myc oncogenesis, and provide the evidence for the potential application of HDAC5 inhibitors in the therapy of N-Myc-induced neuroblastoma and potentially other c-Myc-induced malignancies.
Insights
The N-Myc oncoprotein drives neuroblastoma by upregulating histone deacetylase 5 (HDAC5). HDAC5 acts as a co-factor, promoting cancer cell proliferation and blocking differentiation, suggesting HDAC5 inhibitors as a potential therapy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- N-Myc oncoprotein drives neuroblastoma by disrupting gene expression, leading to blocked cell differentiation and proliferation.
- Histone deacetylase 5 (HDAC5) is a transcriptional repressor known to inhibit cell differentiation.
Purpose of the Study:
- To investigate the role of HDAC5 in N-Myc-induced neuroblastoma.
- To elucidate the molecular mechanisms by which HDAC5 contributes to neuroblastoma pathogenesis.
Main Methods:
- Genome-wide gene expression analysis.
- Protein co-immunoprecipitation assays.
- Analysis of HDAC5 and N-Myc expression in neuroblastoma cells.
Main Results:
- N-Myc was found to upregulate HDAC5 expression in neuroblastoma cells.
- HDAC5 repressed NEDD4 and increased Aurora A expression, leading to N-Myc protein upregulation.
- HDAC5 and N-Myc formed a complex to repress a common gene subset, while HDAC5 also acted independently with SIRT2.
- HDAC5 blocked neuroblastoma cell differentiation and promoted proliferation.
Conclusions:
- HDAC5 is identified as a novel co-factor in N-Myc oncogenesis.
- HDAC5 plays a critical role in promoting neuroblastoma cell proliferation and inhibiting differentiation.
- HDAC5 inhibitors represent a potential therapeutic strategy for N-Myc-induced neuroblastoma and other c-Myc-related malignancies.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Methods of Nuclear Reprogramming
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Negative Regulator Molecules
